Western Alliance Bancorporation vs Zoetis Inc — how do they compare? Western Alliance Bancorporation trades at $81.46 (market cap $8.89B), while Zoetis Inc trades at $74.9 (market cap $31.14B). The key difference: Zoetis Inc is far larger — about 3.5× Western Alliance Bancorporation's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| WAL | ZTS | |
|---|---|---|
Market Cap | $8.89B | $31.14B |
Sector | Financials | Health |
52-Week High | $96.08 | $156.76 |
52-Week Low | $66.70 | $71.91 |
Dividend Yield | 2.06% | 2.81% |
Enterprise Value | — | $38.70B |
Trailing returns across standard periods
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →